Latest immunotherapy news
Adding Pembrolizumab to Standard Care Ups Event-Free Survival in Head, Neck Cancer
posted June 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Monjuvi for Relapsed, Refractory Follicular Lymphoma
posted June 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Mitochondrial Genetics Key to Metastatic Melanoma Immunotherapy Resistance
posted June 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer
posted June 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
All-Cause Mortality Elevated for Adult Five-Year Survivors of Hodgkin Lymphoma 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors Related Articles
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer 
Omalizumab, Multiallergen OIT Both Viable for Multifood Allergy Treatment 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine 
Indefinite-Duration Maintenance Therapy No Better Than Fixed-Duration Therapy in Multiple Myeloma Monthly Specialist Briefings
Stay Connected
